Clover Health Investments Corp. (CLOV) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3401 MALLORY LANE, SUITE 210 FRANKLIN, TN 37067 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 6324 - Hospital and Medical Service Plans (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 379,052 | 342,354 | 242,685 | 517,121 | 520,597 | 416,597 | |||
| Cash and cash equivalents | 254,771 | 208,255 | 122,863 | 299,014 | 310,079 | 190,562 | |||
| Short-term investments | 124,281 | 134,099 | 119,822 | 218,107 | 210,518 | 226,035 | |||
| Restricted cash and investments | 53,631 | 52,730 | 82,730 | 82,730 | |||||
| Prepaid expense | 14,517 | 16,761 | 14,418 | 15,226 | 15,245 | 16,898 | |||
| Disposal group, including discontinued operation | 10,064 | 10,926 | |||||||
| Deposits current assets | 542 | 740 | 55,631 | 50,209 | 81,329 | 80,329 | |||
| Other current assets | 3,539 | 4,949 | 1,404 | 1,033 | 2,901 | 2,771 | |||
| Other undisclosed current assets | 141,862 | 177,007 | 60,201 | 279,381 | 426,126 | 674,934 | |||
| Total current assets: | 549,576 | 552,737 | 427,970 | 915,700 | 1,128,928 | 1,274,259 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 2,858 | 3,124 | 3,382 | 3,620 | 3,868 | 4,109 | |||
| Property, plant and equipment | 5,276 | 5,209 | 5,082 | 4,572 | 4,616 | 4,547 | |||
| Long-term investments and receivables | 103,764 | 97,925 | 121,001 | 102,192 | 86,492 | 135,873 | |||
| Long-term investments | 103,764 | 97,925 | 121,001 | 102,192 | 86,492 | 135,873 | |||
| Intangible assets, net (including goodwill), including: | 2,990 | 2,990 | 2,990 | 19,190 | 19,460 | 20,000 | |||
| Other undisclosed intangible assets, net (including goodwill) | 2,990 | 2,990 | 2,990 | 19,190 | 19,460 | 20,000 | |||
| Other noncurrent assets | 9,746 | 9,785 | 10,246 | 14,523 | 14,633 | 14,801 | |||
| Total noncurrent assets: | 124,634 | 119,033 | 142,701 | 144,097 | 129,069 | 179,330 | |||
| TOTAL ASSETS: | 674,210 | 671,770 | 570,671 | 1,059,797 | 1,257,997 | 1,453,589 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 40,441 | 35,408 | 37,184 | 35,296 | 39,919 | 47,452 | |||
| Other undisclosed accounts payable and accrued liabilities | 40,441 | 35,408 | 37,184 | 35,296 | 39,919 | 47,452 | |||
| Deferred revenue | 13 | 3,099 | 103,295 | 113,537 | 107,563 | ||||
| Disposal group, including discontinued operation | 48,773 | 50,622 | |||||||
| Other liabilities | 1,173 | ||||||||
| Due to related parties | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1,331 | ||
| Other undisclosed current liabilities | 235,284 | 270,359 | 220,832 | 580,105 | 754,302 | 952,855 | |||
| Total current liabilities: | 324,511 | 356,389 | 261,115 | 718,696 | 907,758 | 1,110,374 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 24,811 | 22,907 | 23,162 | 19,249 | 19,669 | 20,108 | |||
| Other liabilities | 22,292 | 20,190 | 20,164 | 15,957 | 16,063 | 16,200 | |||
| Operating lease, liability | 2,519 | 2,717 | 2,998 | 3,292 | 3,606 | 3,908 | |||
| Total noncurrent liabilities: | 24,811 | 22,907 | 23,162 | 19,249 | 19,669 | 20,108 | |||
| Total liabilities: | 349,322 | 379,296 | 284,277 | 737,945 | 927,427 | 1,130,482 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 324,838 | 292,424 | 286,345 | 321,805 | 330,524 | 323,107 | |||
| Treasury stock, value | (19,306) | (16,088) | (12,729) | (11,902) | (9,908) | (9,491) | |||
| Additional paid in capital | 2,517,959 | 2,490,036 | 2,461,238 | 2,428,101 | 2,395,000 | 2,358,622 | |||
| Accumulated other comprehensive income (loss) | (2,259) | (2,560) | (2,370) | (5,072) | (6,715) | (7,031) | |||
| Accumulated deficit | (2,171,556) | (2,178,964) | (2,159,794) | (2,089,322) | (2,047,853) | (2,019,039) | |||
| Other undisclosed equity, attributable to parent | 46 | ||||||||
| Other undisclosed equity | 50 | 50 | 49 | 47 | 46 | ||||
| Total equity: | 324,888 | 292,474 | 286,394 | 321,852 | 330,570 | 323,107 | |||
| TOTAL LIABILITIES AND EQUITY: | 674,210 | 671,770 | 570,671 | 1,059,797 | 1,257,997 | 1,453,589 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 356,260 | 346,922 | 510,251 | 482,066 | 513,628 | 527,775 | ||
| Premiums earned, net | 349,900 | 341,722 | 303,070 | 301,230 | 314,383 | 317,086 | ||
| Cost of revenue (Policyholder Benefits and Claims Incurred, Net) | (248,347) | (265,162) | (447,985) | (418,959) | (436,954) | (472,490) | ||
| Gross profit: | 107,913 | 81,760 | 62,266 | 63,107 | 76,674 | 55,285 | ||
| Operating expenses | (349,073) | (369,625) | (575,911) | (523,535) | (542,435) | (600,381) | ||
| Other undisclosed operating income | 248,347 | 265,162 | 447,985 | 418,959 | 436,954 | 472,490 | ||
| Operating income (loss): | 7,187 | (22,703) | (65,660) | (41,469) | (28,807) | (72,606) | ||
| Nonoperating expense (Investment Income, Nonoperating) | (467) | |||||||
| Interest and debt expense | (7) | |||||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (4,726) | |||||||
| Income (loss) from continuing operations before income taxes: | 7,187 | (23,170) | (70,386) | (41,469) | (28,814) | (72,606) | ||
| Other undisclosed loss from continuing operations | (17) | |||||||
| Income (loss) from continuing operations: | 7,170 | (23,170) | (70,386) | (41,469) | (28,814) | (72,606) | ||
| Income (loss) from discontinued operations | 238 | 4,000 | ||||||
| Other undisclosed net loss | (86) | |||||||
| Net income (loss) available to common stockholders, diluted: | 7,408 | (19,170) | (70,472) | (41,469) | (28,814) | (72,606) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 7,408 | (19,170) | (70,472) | (41,469) | (28,814) | (72,606) | ||
| Comprehensive income (loss): | 7,408 | (19,170) | (70,472) | (41,469) | (28,814) | (72,606) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 301 | (190) | 2,702 | 1,643 | 316 | 2,343 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 7,709 | (19,360) | (67,770) | (39,826) | (28,498) | (70,263) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.